SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Ocular Therapeutix Q1 GAAP EPS $(0.410) May Not Compare $(0.370) Estimate, Sales $2.600M Miss $2.840M Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.410) per share which missed the analyst consensus estimate of $(0.370) by 10.81 percent. This is a 8.89 percent increase over losses of $(0.450) per share

Benzinga · 05/08/2020 11:12

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.410) per share which missed the analyst consensus estimate of $(0.370) by 10.81 percent. This is a 8.89 percent increase over losses of $(0.450) per share from the same period last year. The company reported quarterly sales of $2.600 million which missed the analyst consensus estimate of $2.840 million by 8.45 percent. This is a 428.46 percent increase over sales of $492.000 thousand the same period last year.